Di Han

459 total citations
32 papers, 328 citations indexed

About

Di Han is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Di Han has authored 32 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Di Han's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (4 papers). Di Han is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (4 papers). Di Han collaborates with scholars based in China, United States and Canada. Di Han's co-authors include Yong Xu, Xianmei Zhou, Fanchao Feng, Cheng Gu, Hailang He, Qi Wu, Zhichao Wang, Yun Wei, Zhichao Wang and Zichen Luo and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Agricultural and Food Chemistry and CHEST Journal.

In The Last Decade

Di Han

29 papers receiving 323 citations

Peers

Di Han
Fanchao Feng China
Hayato Urushima Japan
Norihiko Funaguchi Japan
Lixing Cao China
Zhang Li China
Hong Seok Choi South Korea
Xuming Ji China
Dazhi Sun China
Jiedong Zhou China
Hongmei Piao China
Fanchao Feng China
Di Han
Citations per year, relative to Di Han Di Han (= 1×) peers Fanchao Feng

Countries citing papers authored by Di Han

Since Specialization
Citations

This map shows the geographic impact of Di Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Han more than expected).

Fields of papers citing papers by Di Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Han. The network helps show where Di Han may publish in the future.

Co-authorship network of co-authors of Di Han

This figure shows the co-authorship network connecting the top 25 collaborators of Di Han. A scholar is included among the top collaborators of Di Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Han. Di Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yue, Di Han, Qingfeng Yu, et al.. (2025). Design, Synthesis, and Evaluation of Novel Isoxazoline Derivatives as Potent GABA Receptor Modulators. Journal of Agricultural and Food Chemistry. 73(33). 20653–20663.
2.
3.
4.
5.
6.
7.
Zhu, Dongwei, Yong Xu, Fanchao Feng, et al.. (2022). Effect of kangai injection combined with platinum-based chemotherapy on the immune function of patients with advanced non-small-cell lung cancer: A meta-analysis. Phytomedicine. 100. 154088–154088. 6 indexed citations
8.
Yang, Shuang, Yong Xu, Di Han, et al.. (2021). Chinese herbal medicine for symptoms of depression and anxiety in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Complementary Therapies in Clinical Practice. 45. 101470–101470. 5 indexed citations
9.
Xu, Yong, Di Han, Zhichao Wang, et al.. (2021). Material Basis and Mechanism of Chansu Injection for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking Technology. Evidence-based Complementary and Alternative Medicine. 2021. 1–11. 6 indexed citations
10.
Xu, Yong, Fanchao Feng, Cheng Gu, et al.. (2021). Meta-Analysis of Therapy of Cinobufacini Capsule Adjunct with First-Line Platinum-Based Chemotherapy for the Treatment of Advanced NSCLC. Evidence-based Complementary and Alternative Medicine. 2021. 1–18. 7 indexed citations
11.
Han, Di, et al.. (2021). LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells. Frontiers in Pharmacology. 12. 732716–732716. 19 indexed citations
12.
Wang, Zhichao, Fanchao Feng, Hailang He, et al.. (2021). Citrus alkaline extracts prevent endoplasmic reticulum stress in type II alveolar epithelial cells to ameliorate pulmonary fibrosis via the ATF3/PINK1 pathway. Phytomedicine. 89. 153599–153599. 18 indexed citations
13.
Xu, Yong, Di Han, Fanchao Feng, et al.. (2021). Maiwei Yangfei decoction prevents bleomycin‑induced pulmonary fibrosis in mice. Experimental and Therapeutic Medicine. 22(5). 1306–1306. 7 indexed citations
14.
Gu, Cheng, et al.. (2020). Suhuang Zhike Capsules for the Treatment of Cough Variant Asthma: A Meta‐analysis. Evidence-based Complementary and Alternative Medicine. 2020(1). 9485746–9485746. 6 indexed citations
15.
Feng, Fanchao, Jingyi Huang, Zhichao Wang, et al.. (2020). Xiao-ai-ping injection adjunct with platinum-based chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis. BMC Complementary Medicine and Therapies. 20(1). 3–3. 15 indexed citations
16.
Xu, Yong, Di Han, Zhichao Wang, et al.. (2020). Combined Treatment of Non‐Small‐Cell Lung Cancer Using Shenyi Capsule and Platinum‐Based Chemotherapy: A Meta‐Analysis and Systematic Review. Evidence-based Complementary and Alternative Medicine. 2020(1). 3957193–3957193. 6 indexed citations
17.
Feng, Fanchao, Zhichao Wang, Qi Wu, et al.. (2019). Citrus alkaline extracts prevent fibroblast senescence to ameliorate pulmonary fibrosis via activation of COX-2. Biomedicine & Pharmacotherapy. 112. 108669–108669. 34 indexed citations
18.
Tang, Weiwei, Xiongxiong Pan, Di Han, et al.. (2019). Clinical significance of CD8+ T cell immunoreceptor with Ig and ITIM domains+ in locally advanced gastric cancer treated with SOX regimen after D2 gastrectomy. OncoImmunology. 8(6). e1593807–e1593807. 33 indexed citations
19.
20.
Jo, Kang-Hyun, Di Han, & Tae Yeal Choi. (2005). Evaluation of Four Methods for Antimicrobial Susceptibility Testing of Helicobacter pylori in Routine Practice.. Korean Journal of Clinical Microbiology. 8(1). 82–89. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fanchao Feng Breakdown of academic impact, for papers by Hayato Urushima Breakdown of academic impact, for papers by Norihiko Funaguchi Breakdown of academic impact, for papers by Lixing Cao Breakdown of academic impact, for papers by Zhang Li Breakdown of academic impact, for papers by Hong Seok Choi Breakdown of academic impact, for papers by Xuming Ji Breakdown of academic impact, for papers by Dazhi Sun Breakdown of academic impact, for papers by Jiedong Zhou Breakdown of academic impact, for papers by Hongmei Piao
Rankless by CCL
2026